Exelixis (NASDAQ:EXEL) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says
Exelixis (NASDAQ:EXEL – Get Free Report) had its price target lifted by equities researchers at Royal Bank of Canada from $38.00 to $40.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has an “outperform” rating on the biotechnology company’s stock. Royal Bank of Canada’s price target would indicate […]
More Stories
US Annual Inflation Rate Stabilizes in July, Slowing to 3.4 Percent
By Andrew Moran Stabilizing energy prices have helped cool off inflation pressures for the second straight month, new government data...
State Department Launches Birth Tourism Prevention Task Force
By Troy Myers The Department of State on Wednesday announced the existence of a task force that has already revoked...
Todd Blanche Sworn In as Attorney General
By Kimberly Hayek Todd Blanche, President Donald Trump’s former personal lawyer, was sworn in Monday as U.S. attorney general and...
16,000 Arrests Made as Part of Operation to Make Washington Safe
By Naveen Athrappully More than 16,000 individuals have been arrested in Washington since the launch of the Make D.C. Safe...
Commercial Chapter 11 Bankruptcy Filings Decrease Annually
By Naveen Athrappully There were 666 commercial Chapter 11 bankruptcy filings made in the United States in July, a 27...
Syrian Court Sentences Ex-President Bashar Assad to Death
By Tom Ozimek A Syrian court sentenced ousted leader Bashar al-Assad to death on Tuesday, convicting him of crimes committed...